Skip to main content
. 2019 Jun 27;14(6):e0218737. doi: 10.1371/journal.pone.0218737

Fig 3. Shikonin inhibits bladder cancer cell proliferation.

Fig 3

UM-UC3, HTB-9, and HTB-5 cells were treated with shikonin under three different glucose concentrations 25 mg/dL, 100 mg/dL, and 200 mg/dL. Data were analyzed from three independent experiments, each data point represents the mean ± S.E.M. * indicates significant two-tailed t-test p value of < 0.05, compared with vehicle-treated (DMSO) control.